Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

The recent formation of the FIBRE Consortium, a collaboration involving Pfizer (NYSE:PFE) and other pharmaceutical partners, ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer (NYSE:PFE) and its peers. The branded pharmaceutical industry relies on a ...

Pfizer—the maker of Paxlovid—has begun Phase 3 clinical trials of a next-generation coronavirus antiviral, ibuzatrelvir. Ibuzatrelvir offers several advantages over its predecessor.

Pfizer announced Jeffrey Legos ... CorVista Health appointed Adrian Lam as CEO. Santhera Pharmaceuticals named Catherine Isted as CFO. LB Pharmaceuticals named Gad Soffer as chief business officer and ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...